Midodrine's Cardiac Rhythm Effects

Clinical Significance and Monitoring

• The American College of Cardiology recommends monitoring for bradycardia as a primary cardiovascular parameter when initiating or adjusting midodrine therapy, with a strength of evidence level not specified 1
• Blood pressure should be monitored in both supine and standing positions to assess efficacy and detect supine hypertension, as recommended by the American Heart Association 1
• Withhold midodrine if the patient develops supine systolic hypertension or bradycardia, as these are the primary safety concerns requiring cessation, according to the American College of Cardiology 1

High-Risk Cardiac Interactions and Special Populations

• The European Society of Cardiology notes that cardiac glycosides (digoxin) may enhance or precipitate bradycardia, AV block, or arrhythmias when combined with midodrine, with a strength of evidence level not specified 1
• Caution is required with concomitant use of other negative chronotropic agents, including beta-blockers, non-dihydropyridine calcium channel blockers, and psychopharmacologic agents that reduce heart rate, as recommended by the European Heart Journal 2
• The American College of Cardiology recommends using midodrine with caution in patients with congestive heart failure, as it may be poorly tolerated, with a strength of evidence level not specified 1

Blood Pressure Effects on Cardiac Function

• The European Heart Journal notes that midodrine has no clinically significant effect on standing or supine pulse rates in patients with autonomic failure, confirming the rhythm effects are primarily reflex-mediated, with a strength of evidence level not specified 2